Innovative Ubar technology
The story of the technology company Embryonics began in the Israeli city of Haifa in 2018. It was this company that introduced its advanced system called Ubar to the world. This development implements artificial intelligence in in vitro fertilization and is based on an in-depth analysis of embryo development processes. It is based on complex machine learning algorithms. Ubar’s main goal is both simple and ambitious. It is necessary to select the most viable and promising embryos with the highest possible accuracy for transfer to the uterine cavity. This is a critically important stage of the IVF (in vitro fertilization) procedure.
Key advantages of using Ubar
The official data from the developer sounds impressive. The application of this technology has made it possible to achieve significant results and significantly exceed human capabilities. The accuracy of predicting successful implantation using Ubar exceeded the results of the experimental group of embryologists by 20 percent. These figures are not just words; they have been confirmed in several comparative studies involving specialists.
Ubar technology has also demonstrated high efficiency in the opposite direction. It was 30 percent more accurate in identifying embryos that have the least chance of successful implantation. The creators emphasize the importance of this approach. It will significantly reduce the number of unsuccessful attempts. This will help couples undergoing complex infertility treatment to save significant funds and avoid cycles that are obviously futile.
How the system works
Embryonics uses the latest advances in artificial intelligence. Ubar technology was trained on a huge array of data. Tens of thousands of cycles and detailed frame-by-frame video recordings of embryo development were analyzed.
The system sees what escapes the human eye. It analyzes literally every stage of growth and identifies the slightest changes. These micro-movements can serve as indicators of viability and implantation potential. In addition to embryo selection, the company successfully uses the technology to assess the quality of oocytes. This opens up new prospects for deferred motherhood programs and increases the effectiveness of IVF programs with egg donation, where the quality of biomaterial plays a decisive role.
Expert opinion of management
The company’s CEO, Dr. Yael Zamir, highlighted an important nuance. The purpose of Ubar technology is not to imitate human actions. The system does not attempt to replace the doctor. It serves as a powerful tool for increasing the accuracy of selecting the best embryos.
Dr. Zamir also cited data from several clinical trials involving real patients. The introduction of this technology can increase the overall success rate of procedures by 10 percent.
Prospects and new developments
The Embryonics team is not resting on its laurels. Work on the implementation of artificial intelligence to improve reproductive technologies continues. The developers’ goal is to provide more choices for couples facing the difficult problem of infertility. This includes complex cases requiring IVF with double donation.
The integration of machine learning with deep data analysis methods paves the way for the creation of fundamentally new diagnostic tools. In the field of reproductive medicine, every stage is important and affects the final outcome. Such innovations can radically change the very approach to therapy.
Monitoring and looking to the future
The company plans to use its developments not only for selection. It is important to organize careful and continuous monitoring of embryo development at all stages. This will contribute to improved health indicators and an increase in the frequency of successful implantations.
The widespread use of Ubar technology is designed to reduce the emotional and financial burden on patients. The system will provide doctors with more accurate and objective data for making informed decisions about further treatment tactics. Artificial intelligence technologies are becoming an integral part of the process. They allow for highly accurate predictions and actually increase the chances of success, helping many couples realize their dream of starting a family.
Frequently asked questions
Question 1. Does Ubar technology replace the embryologist? No, Ubar technology is not designed to replace humans. As Embryonics CEO Dr. Yael Zamir stated, the system does not imitate the work of an expert. It serves as a support tool to improve the accuracy of embryo selection and helps doctors make more informed decisions.
Question 2. How much more accurate is the system than humans in its predictions? According to company data and comparative studies, Ubar’s accuracy in predicting successful implantation is 20 percent higher than that of a group of embryologists. The system is 30 percent more accurate in identifying non-viable embryos.
Question 3. What data does Ubar use for analysis? The technology has been trained on tens of thousands of cycles. The main source of data is frame-by-frame video recordings of embryo development. They allow the algorithm to notice the slightest changes at each stage of growth.
Question 4. Can this technology only be used for embryos? No, the company also uses this technology to select and evaluate the quality of eggs. This is especially relevant for deferred motherhood programs, as well as IVF protocols with egg donation, helping to select the highest quality oocytes.
Question 5. How does this affect the cost of treatment for patients? The developers claim that increased selection accuracy reduces the number of unsuccessful cycles. Each attempt is expensive, so reducing the number of empty attempts helps patients save money and reduce emotional stress.
